PhaseBio Pharmaceuticals Inc SBIR Phase II Award, August 2018
A SBIR Phase II contract was awarded to Phasebio Pharmaceuticals, Inc. in August, 2018 for $2,497,273.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Is a
Award Amount (USD)
2,497,273
0
Government Branch
Date Awarded
August 1, 2018
0
End Date
July 31, 2020
0
SBIR/STTR Award Recipient
Contract Number (US Government)
4R44HL140690-02
0
Award Phase
Phase II
0
Award Type
SBIR
0
Official Website
Find more entities like PhaseBio Pharmaceuticals Inc SBIR Phase II Award, August 2018
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
